CoChat

ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 Working Group

Goel, Ruchika, Bloch, Evan M., Pirenne, France, Al‐Riyami, Arwa Z., Crowe, Elizabeth, Dau, Laetitia, Land, Kevin, Townsend, Mary, Jecko, Thachil, Rahimi‐Levene, Naomi, Patidar, Gopal, Josephson, Cassandra D., Arora, Satyam, Vermeulen, Marion, Vrielink, Hans, Montemayor, Celina, Oreh, Adaeze, Hindawi, Salwa, van den Berg, Karin, Serrano, Katherine, So‐Osman, Cynthia, Wood, Erica, Devine, Dana V., Spitalnik, Steven L., the ISBT COVID‐19 Working Group · 2021 · Vox Sanguinis
Cited by 127

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Growing evidence suggests that ABO blood group may play a role in the immunopathogenesis of SARS‐CoV‐2 infection, with group O individuals less likely to test positive and group A conferring a higher susceptibility to infection and propensity to severe disease. The level of evidence supporting an association between ABO type and SARS‐CoV‐2/COVID‐19 ranges from small observational studies, to genome‐wide‐association‐analyses and country‐level meta‐regression analyses. ABO blood group antigens are oligosaccharides expressed on red cells and other tissues (notably endothelium). There are several hypotheses to explain the differences in SARS‐CoV‐2 infection by ABO type. For example, anti‐A and/or anti‐B antibodies (e.g. present in group O individuals) could bind to corresponding antigens on the viral envelope and contribute to viral neutralization, thereby preventing target cell infection. The SARS‐CoV‐2 virus and SARS‐CoV spike (S) proteins may be bound by anti‐A isoagglutinins (e.g. present in group O and group B individuals), which may block interactions between virus and angiotensin‐converting‐enzyme‐2‐receptor, thereby preventing entry into lung epithelial cells. ABO type‐associated variations in angiotensin‐converting enzyme‐1 activity and levels of von Willebrand factor (VWF) and factor VIII could also influence adverse outcomes, notably in group A individuals who express high VWF levels. In conclusion, group O may be associated with a lower risk of SARS‐CoV‐2 infection and group A may be associated with a higher risk of SARS‐CoV‐2 infection along with severe disease. However, prospective and mechanistic studies are needed to verify several of the proposed associations. Based on the strength of available studies, there are insufficient data for guiding policy in this regard.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/vox.13076

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 72

  1. 10.1056/NEJMoa2001017 · DOI · Paper page
  2. 10.1182/bloodadvances.2020002657 · DOI · Paper page
  3. 10.1182/bloodadvances.2020002623 · DOI · Paper page
  4. ZhaoJ YangY HuangH‐P et alRelationship between the ABO Blood Group and the COVID‐19 Susceptibility.medRxiv2020.
  5. Latz CA, 2020, Blood type and outcomes in patients with COVID‐19, Ann Hematol, 1
  6. 10.1111/bjh.16811 · DOI · Paper page
  7. 10.1086/341129 · DOI
  8. 10.3389/fimmu.2017.00872 · DOI · Paper page
  9. 10.1111/bjh.16884 · DOI
  10. 10.1111/j.1365-2141.2005.05705.x · DOI
  11. Daniele F, 2020, Anti‐A Isohemagglutinin titers and SARS‐CoV2 neutralization: implications for children and convalescent plasma selection, Br J Haematol, 190, e148
  12. 10.1146/annurev-pathol-012414-040318 · DOI
  13. 10.1111/trf.13087 · DOI
  14. Mourant AE, 1976, The Distribution of Human Blood Groups and Other Polymorphisms
  15. 10.1002/ajpa.21204 · DOI
  16. 10.1111/j.1423-0410.1989.tb03040.x · DOI · Paper page
  17. Dean L, 2005, Blood Groups and Red Cell Antigens
  18. 10.3389/fimmu.2014.00492 · DOI
  19. 10.4048/jbc.2020.23.e13 · DOI
  20. 10.1152/physiolgenomics.00043.2017 · DOI
  21. 10.3324/haematol.10457 · doi:10.3324/haematol.10457
  22. Liumbruno GM, 2013, Beyond immunohaematology: the role of the ABO blood group in human diseases, Blood Transfus, 11, 491
  23. 10.1186/1477-9560-5-14 · DOI · Paper page
  24. 10.1016/j.thromres.2020.05.051 · DOI
  25. 10.1111/j.1538-7836.2007.02818.x · DOI · Paper page
  26. 10.1038/204192a0 · doi:10.1038/204192a0
  27. 10.1034/j.1600-0463.2000.d01-1.x · DOI · Paper page
  28. 10.4155/fsoa-2015-0012 · DOI
  29. 10.1371/journal.pone.0051441 · DOI
  30. 10.1186/s12916-014-0250-y · DOI
  31. 10.1111/jth.13551 · DOI · Paper page
  32. 10.1007/978-3-642-59086-3_10 · DOI
  33. 10.1128/CMR.00109-14 · DOI · Paper page
  34. 10.1016/j.virol.2004.11.037 · doi:10.1016/j.virol.2004.11.037
  35. 10.1182/blood-2005-02-0536 · DOI · Paper page
  36. 10.1182/blood-2003-05-1522 · DOI · Paper page
  37. 10.1093/infdis/172.5.1198 · DOI
  38. 10.1056/NEJM199404283301704 · doi:10.1056/nejm199404283301704
  39. 10.1126/science.8018146 · DOI · Paper page
  40. 10.1093/glycob/cws072 · DOI · Paper page
  41. 10.1126/science.1098801 · DOI · Paper page
  42. 10.1038/s41598-018-36006-x · DOI · Paper page
  43. 10.1001/jama.293.12.1450-c · DOI · Paper page
  44. 10.1111/bjh.16984 · DOI
  45. 10.3906/sag-2005-395 · DOI · Paper page
  46. 10.30699/ijp.2020.125135.2367 · DOI
  47. ZengX FanH LuD et al.:Association between ABO blood groups and clinical outcome of coronavirus disease 2019: Evidence from two cohorts. medRxiv2020. · DOI
  48. 10.1016/j.cca.2020.06.026 · doi:10.1016/j.cca.2020.06.026
  49. 10.1111/trf.15415 · DOI
  50. 10.1093/ije/dyt095 · DOI
  51. 10.1111/bjh.17059 · doi:10.1111/bjh.17059
  52. ZietzM TatonettiNP:Testing the association between blood type and COVID‐19 infection intubation and death. medRxiv2020. · DOI
  53. 10.1056/NEJMoa2020283 · DOI · Paper page
  54. 10.1371/journal.ppat.1008556 · DOI
  55. 10.1126/science.1116480 · DOI · Paper page
  56. 10.1074/mcp.M300048-MCP200 · DOI · Paper page
  57. 10.1002/pmic.200300676 · DOI
  58. 10.1126/science.abb9983 · DOI · Paper page
  59. 10.1093/glycob/cwn093 · DOI · Paper page
  60. 10.1371/journal.ppat.1008556 · DOI
  61. Wu S, 2020, SARS‐CoV‐2 Receptor Binding Domain Preferentially Recognizes Blood Group A, Blood Adv
  62. 10.5581/1516-8484.20110073 · doi:10.5581/1516-8484.20110073
  63. 10.4103/0973-6247.200765 · doi:10.4103/0973-6247.200765
  64. 10.1016/j.antiviral.2020.104880 · DOI
  65. 10.1046/j.1537-2995.1991.31791368336.x · DOI
  66. 10.1182/blood-2010-01-261859 · DOI · Paper page
  67. 10.1177/2047487320922370 · DOI
  68. 10.1001/jama.2020.13372 · DOI · Paper page
  69. 10.1046/j.1365-3148.2001.00315.x · DOI · Paper page
  70. 10.1111/vox.12970 · DOI
  71. Al‐Riyami AZ, 2020, Clinical use of Convalescent Plasma in the COVID‐19 pandemic: a transfusion‐focussed gap analysis with recommendations for future research priorities, Vox Sang
  72. Bloch EM, 2020, ABO blood group and SARS‐CoV‐2 antibody response in a convalescent donor population, Vox Sang

Cited by

Metadata

Authors
Goel, R., Bloch, E. M., Pirenne, F., Al‐Riyami, A. Z., Crowe, E., Dau, L., Land, K., Townsend, M., Jecko, T., Rahimi‐Levene, N., Patidar, G., Josephson, C. D., Arora, S., Vermeulen, M., Vrielink, H., Montemayor, C., Oreh, A., Hindawi, S., van den Berg, K., Serrano, K., So‐Osman, C., Wood, E., Devine, D. V., Spitalnik, S. L., & the ISBT COVID‐19 Working Group
Affiliations
  • Department of Pathology Johns Hopkins University School of Medicine Baltimore MD USA
  • Etablissement Français du Sang Ile de France Hôpital Henri Mondor Créteil France
  • Department of Hematology Sultan Qaboos University Hospital Muscat Sultanate of Oman
  • Vitalant Scottsdale AZ USA
  • Manchester University NHS Manchester UK
  • Shamir Medical Center Be'er Ya'akov Israel
  • Department of Transfusion Medicine All India Institute of Medical Sciences New Delhi India
  • Department of Pathology Emory University Atlanta GA USA
  • Super Speciality Pediatric Hospital and Post Graduate Teaching Institute Noida India
  • The South African National Blood Service Port Elizabeth South Africa
  • Dept Unit Transfusion Medicine Sanquin Bloodbank Amsterdam the Netherlands
  • Canadian Blood Services Ottawa ON Canada
  • National Blood Transfusion Service Department of Hospital Services Federal Ministry of Health Abuja Nigeria
  • King Abdalaziz University Jeddah Saudi Arabia
  • Translational Research Department Medical Division South African National Blood Service Port Elizabeth South Africa
  • Canadian Blood Services Vancouver BC Canada
  • Monash University Melbourne VIC Australia
  • Department of Pathology & Cell Biology Columbia University New York NY USA
Venue
Vox Sanguinis
Publisher
Wiley
Published
2021-02-12
Volume
116
Issue
8
Pages
849-861
ISSN
  • 0042-9007
  • 1423-0410
Cited by
127
References
6
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.